BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/15/2023 12:44:08 AM | Browse: 242 | Download: 819
 |
Received |
|
2022-09-24 01:46 |
 |
Peer-Review Started |
|
2022-09-24 01:47 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2022-10-20 14:30 |
 |
Revised |
|
2022-11-03 10:16 |
 |
Second Decision |
|
2023-01-10 03:34 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2023-01-10 18:15 |
 |
Articles in Press |
|
2023-01-10 18:15 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2022-12-26 23:45 |
 |
Typeset the Manuscript |
|
2023-02-07 06:41 |
 |
Publish the Manuscript Online |
|
2023-02-15 00:44 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Immunology |
Manuscript Type |
Review |
Article Title |
Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jonadab E Olguin, Monica G Mendoza-Rodriguez, C Angel Sanchez-Barrera and Luis I Terrazas |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Luis I Terrazas, PhD, Chairman, Senior Scientist, Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Avenida de los Barrios # 1, Tlalnepantla 54090, Estado de Mexico, Mexico. literrazas@unam.mx |
Key Words |
Colorectal cancer; Immunotherapy checkpoint inhibitors; Chemotherapy; Immunotherapy; Immune response |
Core Tip |
This review focused on the drugs that may modulate the immune response and show specific efficacy in the treatment of colorectal cancer. We then presented the evidence that immunosuppression or promotion of the immune response is the answer to generating effective treatments with combined chemotherapeutic drugs. |
Publish Date |
2023-02-15 00:44 |
Citation |
Olguin JE, Mendoza-Rodriguez MG, Sanchez-Barrera CA, Terrazas LI. Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment? . World J Gastrointest Oncol 2023; 15(2): 251-267 |
URL |
https://www.wjgnet.com/1948-5204/full/v15/i2/251.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v15.i2.251 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345